MetLife, Inc. (NYSE:MET) Shares Purchased by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. increased its position in shares of MetLife, Inc. (NYSE:MET) by 42.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 25,541 shares of the financial services provider’s stock after purchasing an additional 7,628 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in MetLife were worth $2,091,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of MET. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of MetLife by 1.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock valued at $375,179,000 after acquiring an additional 68,579 shares in the last quarter. Nordea Investment Management AB lifted its position in shares of MetLife by 16.8% in the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after acquiring an additional 608,224 shares in the last quarter. Swedbank AB lifted its position in shares of MetLife by 76.0% in the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after acquiring an additional 1,496,645 shares in the last quarter. Jennison Associates LLC lifted its position in shares of MetLife by 3.6% in the fourth quarter. Jennison Associates LLC now owns 3,274,258 shares of the financial services provider’s stock valued at $268,096,000 after acquiring an additional 114,166 shares in the last quarter. Finally, Stifel Financial Corp lifted its position in shares of MetLife by 5.0% in the third quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock valued at $184,744,000 after acquiring an additional 105,762 shares in the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Stock Performance

Shares of NYSE:MET opened at $81.02 on Friday. The firm has a market capitalization of $56.10 billion, a PE ratio of 13.57, a P/E/G ratio of 0.65 and a beta of 1.07. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The business has a 50-day moving average of $83.41 and a two-hundred day moving average of $81.44. MetLife, Inc. has a 12 month low of $67.30 and a 12 month high of $89.05.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, research analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.69%. MetLife’s dividend payout ratio (DPR) is currently 36.52%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on MET. Barclays reduced their target price on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. TD Cowen increased their target price on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Wells Fargo & Company increased their target price on MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Keefe, Bruyette & Woods reduced their target price on MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 12th. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, MetLife presently has an average rating of “Moderate Buy” and a consensus price target of $92.58.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.